|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 592.8 INR | +2.21% |
|
+2.60% | +45.69% |
Unichem Laboratories Limited announced that it has received ANDA approval for its Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Cardura®? (Doxazosin) Tablets, 1 mg, 4 mg and 8 mg. Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure.
The product will be commercialized from Unichem's Goa Plant.
| 1st Jan change | Capi. | |
|---|---|---|
| +45.69% | 500M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
UNICHEM LABORATORIES LIMITED 
